-transparent.png){kind=logo}
OBJECTIVE To evaluate the efficacy of probucol on ischemia-reperfusion injury in the isolated working rat heart. METHODS Twelve male Sprague-Dawley rats were divided into two groups: one was fed normal chow (group C) and the other was fed chow containing 1% probucol for four weeks (group P). Samples of heart organ and blood were then taken under anesthesia. Isolated hearts were perfused in a working heart model. After 5 mins of perfusion in aerobic conditions, global ischemia was induced for 15 mins, the hearts were then reperfused. Aortic and coronary flow, cardiac function and electrocardiogram were monitored throughout the experiment, including a 20 min period of reperfusion. Serum lipids and lipid peroxide were also measured in each rat. RESULTS Rats in group P (probucol-treated) had significantly lower levels of serum cholesterol, triglyceride and phospholipid than those in group C (controls). Serum lipid peroxide was also significantly lower in group P than in group C rats (P < 0.05). The incidence of ventricular arrhythmias in the ischemia and reperfusion stages was lower in group P than in group C (P < 0.001) and the increase in coronary flow during the reperfusion stage was greater in isolated hearts of group P rats than in those of group C (P < 0.05). CONCLUSIONS Probucol may have a protective effect on myocardium with respect to ischemia-reperfusion arrhythmia in the isolated rat heart, presumably due to an antioxidative effect.
N Tada, and
S Mochizuki, and
T Takayama, and
H Yabe, and
S Seki, and
M Taniguchi, and
M Nagano
January 1991,
Yao xue xue bao = Acta pharmaceutica Sinica,
N Tada, and
S Mochizuki, and
T Takayama, and
H Yabe, and
S Seki, and
M Taniguchi, and
M Nagano
April 1999,
Basic research in cardiology,
N Tada, and
S Mochizuki, and
T Takayama, and
H Yabe, and
S Seki, and
M Taniguchi, and
M Nagano
January 1990,
Japanese circulation journal,
N Tada, and
S Mochizuki, and
T Takayama, and
H Yabe, and
S Seki, and
M Taniguchi, and
M Nagano
July 2015,
Cardiovascular toxicology,
N Tada, and
S Mochizuki, and
T Takayama, and
H Yabe, and
S Seki, and
M Taniguchi, and
M Nagano
April 2008,
Sheng li xue bao : [Acta physiologica Sinica],
N Tada, and
S Mochizuki, and
T Takayama, and
H Yabe, and
S Seki, and
M Taniguchi, and
M Nagano
April 2008,
Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue,
N Tada, and
S Mochizuki, and
T Takayama, and
H Yabe, and
S Seki, and
M Taniguchi, and
M Nagano
April 2018,
Fundamental & clinical pharmacology,
N Tada, and
S Mochizuki, and
T Takayama, and
H Yabe, and
S Seki, and
M Taniguchi, and
M Nagano
January 1989,
Pharmacology,
N Tada, and
S Mochizuki, and
T Takayama, and
H Yabe, and
S Seki, and
M Taniguchi, and
M Nagano
January 2006,
Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban,
N Tada, and
S Mochizuki, and
T Takayama, and
H Yabe, and
S Seki, and
M Taniguchi, and
M Nagano
July 2001,
Journal of cardiovascular pharmacology,
